Primus Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsPrimus Pharmaceuticals

Primus Pharmaceuticals

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Impoyz	Clobetasol	2017-11-28	2025-2035	Inflammation , Dermatitis , Facial dermatoses , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses
Metaxalone	Metaxalone	2015-06-01	2026	Myositis , Pain , Muscle spasticity , Muscle cramp , Spasm , Muscle rigidity
Sernivo	Betamethasone	2016-02-05	2027-2039	Psoriasis , Atopic dermatitis , Pruritus ani , Inflammation , Facial dermatoses , Seborrheic dermatitis , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses , Mycoses , Oral candidiasis , Vulvovaginal candidiasis , Tinea pedis , Cutaneous candidiasis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

spinal stenosis

,

,

cognitive dysfunction

,

,

healthy volunteers/patients

healthy volunteers/patients

Clobetasol propionate

healthy volunteers/patients

Betamethasone dipropionate

healthy volunteers/patients

,

,

,

,

,

esophageal neoplasms

,

colorectal neoplasms

,

,

acute lung injury

,

healthy volunteers/patients

,

coronavirus infections

,

therapeutic equivalency

,

,

metabolic syndrome

,

,

,

insulin resistance

,

,

,

,

,

,

,

,

,

,

,

,

,

,

,

muscle weakness

,

,

,

,

non-alcoholic fatty liver disease

,

alcoholic fatty liver

,

metabolic bone diseases

,

,

,

breast neoplasms

,

cardiovascular diseases

,

,

heart disease risk factors

,

,

drug-related side effects and adverse reactions

,

ulcerative colitis

,

rheumatoid arthritis

,

peripheral nervous system diseases

,

venous insufficiency

,

,

,

,

,

venous thrombosis

,

postthrombotic syndrome

,

,

polycystic ovary syndrome

,

,

,

,

body weight changes

,

,

exercise tolerance

,

,

,

,

type 2 diabetes mellitus

,

,

acid-base imbalance

,

psychological power

,

oxidative stress

,

,

telerehabilitation

,

pelvic floor disorders

,

,

,

,

postmenopausal osteoporosis

,

,

,

biological availability

,

prediabetic state

,

diabetic neuropathies

,

,

congenital abnormalities

,

vascular malformations

,

,

systemic scleroderma

,

diffuse scleroderma

,

ovarian hyperstimulation syndrome

,

vascular diseases

,

obstructive sleep apnea

,

,

,

,

cognitive dysfunction

,

dental pulp exposure

,

dental pulp capping

,

,

blood circulation

,

replacement arthroplasty knee

,

,

hematologic neoplasms

,

,

,

metabolic bone diseases

,

,

,

,

breast neoplasms

,

,

,

diabetes mellitus

,

type 2 diabetes mellitus

,

insulin resistance

,

chronic hepatitis c

,

,

,

non-alcoholic fatty liver disease

,

,

type 1 diabetes mellitus

,

,

Bos taurus adrenal cortex corticosteroids

,

knee osteoarthritis

healthy volunteers/patients

,

renal insufficiency

,

critical illness

,

parkinson disease

,

cystic fibrosis

,

,

,

,

,

pituitary dwarfism

,

,

cardiovascular diseases

,

,

body weight changes

,

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

lymphoid leukemia

,

chronic obstructive pulmonary disease

,

gestational diabetes

,

nutrition disorders

,

cardiac surgical procedures

,

,

,

,

diabetes mellitus

,

type 2 diabetes mellitus

,

type 1 diabetes mellitus

,

,

drug delivery systems

,

insulin resistance

,

,

,

atherosclerosis

,

arteriosclerosis

,

,

diabetic ketoacidosis

,

chronic renal insufficiency

,

respiratory insufficiency

,

surgical wound infection

,

latent autoimmune diabetes in adults

,

heart disease risk factors

,

,

patient participation

,

sedentary behavior

1

2

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use